Caffeine in the Prevention of Post-operative Nausea and Vomiting
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine if caffeine 500 mg intravenously is efficacious
when added to standard anti-emetic prophylaxis in the prevention of post-operative nausea and
vomiting (PONV) in patients undergoing ambulatory surgery under general anesthesia.